Citius Pharmaceuticals Inc vs Jabil Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Jabil Inc trades at $362.4 (market cap $37.37B). The key difference: Jabil Inc is far larger — about 1867.6× Citius Pharmaceuticals Inc's market cap, and Jabil Inc pays a 0.09% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | JBL | |
|---|---|---|
Market Cap | $20.01M | $37.37B |
Sector | Health | Technology |
52-Week High | $1.82 | $385.50 |
52-Week Low | $0.48 | $192.49 |
Enterprise Value | $16.23M | $39.90B |
Dividend Yield | — | 0.09% |
Trailing returns across standard periods
Latest headlines on both assets
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.
Read more on JBL →